
Methods: Querying the USVI arbovirus syndromic surveillance system and Emergency Department (ED) records from 2 hospitals, we identified patients in the 2.5 months post-hurricanes demonstrating symptoms consistent with leptospirosis/melioidosis. Available patient blood samples underwent rapid diagnostic testing (RDT) for anti-Leptospira IgM and were sent to the U.S. Centers for Disease Control and Prevention for confirmatory microscopic agglutination testing (MAT). A subset were tested with a B. pseudomallei antigen RDT, and water collected from sites of potential Leptospira-contamination were tested by PCR.
Results: An initial query of the syndromic surveillance database yielded 17 patients warranting testing; 15 available patient samples were tested for leptospirosis and were negative (2 tested for melioidosis—negative). Following efforts to enhance this system to proactively detect leptospirosis/melioidosis, 15 additional patient samples were obtained and tested for leptospirosis; 1 tested positive. We reviewed 5,220 ED charts, identifying 6 patients warranting testing; 5 available patient samples were tested for leptospirosis; 1 tested positive (1 tested for melioidosis—negative). Altogether, as of April 2018, there are 3 leptospirosis and 2 melioidosis confirmed cases in USVI. One of 3 water samples collected from sites associated with patients with leptospirosis tested PCR-positive for Leptospira species.
Conclusion: This investigation documents the first cases of leptospirosis and melioidosis in USVI and demonstrates how USVI’s surveillance system was adapted to establish ongoing leptospirosis/melioidosis surveillance. Collectively, although not confirmed by detection of B. pseudomallei in the environment, both leptospirosis and melioidosis may be endemic in the USVI.

T. Hunte-Ceasar,
None
L. Laplace Ekpo, None
C. Harrison, None
B. Ellis, None
M. Davis, None
E. Ellis, None